Cargando…

Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond

Objective Transcatheter atrial septal defect (ASD) device closure in the older population presents a greater challenge due to the long-standing effect of atrial left-to-right shunt. This study analyzes the challenges encountered in transcatheter ASD device closure in older patients in their fifth de...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhi, Anil K, Mahapatra, Soumya K, Kumar, Dilip, Dey, Somnath, Mishra, Amiya, De, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861837/
https://www.ncbi.nlm.nih.gov/pubmed/35223335
http://dx.doi.org/10.7759/cureus.22480
_version_ 1784654948978393088
author Singhi, Anil K
Mahapatra, Soumya K
Kumar, Dilip
Dey, Somnath
Mishra, Amiya
De, Arnab
author_facet Singhi, Anil K
Mahapatra, Soumya K
Kumar, Dilip
Dey, Somnath
Mishra, Amiya
De, Arnab
author_sort Singhi, Anil K
collection PubMed
description Objective Transcatheter atrial septal defect (ASD) device closure in the older population presents a greater challenge due to the long-standing effect of atrial left-to-right shunt. This study analyzes the challenges encountered in transcatheter ASD device closure in older patients in their fifth decade and beyond. Methods Adults aged 40 years and above with significant secundum ASD who underwent transcatheter ASD device closure between June 2015 and April 2021 were analyzed. Challenges were classified as major and minor challenges based on their impact on the alteration of the treatment protocol. Patients were categorized into three subgroups according to age. Group 1 consisted of patients aged 40-49 years (n = 13), Group 2 consisted of patients aged 50-59 years (n = 16), and Group 3 consisted of patients aged 60 years and above (n = 8). Results A total of 37 patients were analyzed. The challenges encountered were arrhythmia, pulmonary hypertension, left ventricular diastolic dysfunction, bleeding, stroke, coronary artery disease (CAD), hypertension, and airway disease. Thirteen percent of challenges were seen in pre-procedure time, whereas 79% of challenges during the procedure and 8% of challenges during post-procedure were seen. Thirty-five patients (94.6%) underwent transcatheter ASD device closure. Two patients (5.4%) did not undergo transcatheter ASD device closure due to severe diastolic dysfunction and associated CAD, respectively. Eleven major challenges were encountered in 10 patients in which one patient had a dual challenge of bleeding and arrhythmia. Thirteen patients (35.1%) had smooth procedures without any challenges encountered. Twenty-seven minor challenges were encountered in 20 patients with some patients having an overlap of multiple major and minor challenges. The patients were doing well at the mean follow-up of 28 months. Conclusions Transcatheter ASD device closure in older patients who are 40 years and above is safe and effective. Such high-risk patients are prone to various challenges that can be effectively managed if optimally monitored on the basis of a proper understanding of the altered physiology and anticipation of the deviated course at various stages of the procedure.
format Online
Article
Text
id pubmed-8861837
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88618372022-02-25 Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond Singhi, Anil K Mahapatra, Soumya K Kumar, Dilip Dey, Somnath Mishra, Amiya De, Arnab Cureus Cardiology Objective Transcatheter atrial septal defect (ASD) device closure in the older population presents a greater challenge due to the long-standing effect of atrial left-to-right shunt. This study analyzes the challenges encountered in transcatheter ASD device closure in older patients in their fifth decade and beyond. Methods Adults aged 40 years and above with significant secundum ASD who underwent transcatheter ASD device closure between June 2015 and April 2021 were analyzed. Challenges were classified as major and minor challenges based on their impact on the alteration of the treatment protocol. Patients were categorized into three subgroups according to age. Group 1 consisted of patients aged 40-49 years (n = 13), Group 2 consisted of patients aged 50-59 years (n = 16), and Group 3 consisted of patients aged 60 years and above (n = 8). Results A total of 37 patients were analyzed. The challenges encountered were arrhythmia, pulmonary hypertension, left ventricular diastolic dysfunction, bleeding, stroke, coronary artery disease (CAD), hypertension, and airway disease. Thirteen percent of challenges were seen in pre-procedure time, whereas 79% of challenges during the procedure and 8% of challenges during post-procedure were seen. Thirty-five patients (94.6%) underwent transcatheter ASD device closure. Two patients (5.4%) did not undergo transcatheter ASD device closure due to severe diastolic dysfunction and associated CAD, respectively. Eleven major challenges were encountered in 10 patients in which one patient had a dual challenge of bleeding and arrhythmia. Thirteen patients (35.1%) had smooth procedures without any challenges encountered. Twenty-seven minor challenges were encountered in 20 patients with some patients having an overlap of multiple major and minor challenges. The patients were doing well at the mean follow-up of 28 months. Conclusions Transcatheter ASD device closure in older patients who are 40 years and above is safe and effective. Such high-risk patients are prone to various challenges that can be effectively managed if optimally monitored on the basis of a proper understanding of the altered physiology and anticipation of the deviated course at various stages of the procedure. Cureus 2022-02-22 /pmc/articles/PMC8861837/ /pubmed/35223335 http://dx.doi.org/10.7759/cureus.22480 Text en Copyright © 2022, Singhi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Singhi, Anil K
Mahapatra, Soumya K
Kumar, Dilip
Dey, Somnath
Mishra, Amiya
De, Arnab
Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond
title Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond
title_full Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond
title_fullStr Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond
title_full_unstemmed Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond
title_short Challenges in Device Closure of Secundum Atrial Septal Defect in Older Patients in Their Fifth Decade and Beyond
title_sort challenges in device closure of secundum atrial septal defect in older patients in their fifth decade and beyond
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861837/
https://www.ncbi.nlm.nih.gov/pubmed/35223335
http://dx.doi.org/10.7759/cureus.22480
work_keys_str_mv AT singhianilk challengesindeviceclosureofsecundumatrialseptaldefectinolderpatientsintheirfifthdecadeandbeyond
AT mahapatrasoumyak challengesindeviceclosureofsecundumatrialseptaldefectinolderpatientsintheirfifthdecadeandbeyond
AT kumardilip challengesindeviceclosureofsecundumatrialseptaldefectinolderpatientsintheirfifthdecadeandbeyond
AT deysomnath challengesindeviceclosureofsecundumatrialseptaldefectinolderpatientsintheirfifthdecadeandbeyond
AT mishraamiya challengesindeviceclosureofsecundumatrialseptaldefectinolderpatientsintheirfifthdecadeandbeyond
AT dearnab challengesindeviceclosureofsecundumatrialseptaldefectinolderpatientsintheirfifthdecadeandbeyond